# Novo Nordisk A/S (NVO): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/nvo for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Drug Manufacturers - General
- Exchange: NYSE · Trading currency: USD

Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging ther...

## Quote & Key Metrics

As of 2026-10-22:

| Metric | Value |
|---|---|
| Price | $39.43 USD |
| Market Cap | $174.58B |
| P/E (TTM) | 9.81 |
| EPS (TTM) | $4.02 |
| 52-Week Range | $35.12 – $64.16 |
| Dividend Yield (TTM) | 4.56% |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | 4.56% |
| Annual Dividend (TTM) | $1.80 /share |
| Annual Dividend (Forward) | $1.80 /share |
| Frequency | Semi-Annual |
| Consecutive Growth Streak | 1 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | -0.9% / 9.7% / 16.1% / 9.8% |
| Payout Ratio (EPS, TTM) | 44.6% |
| Payout Ratio (FCF, TTM) | 106.3% |
| Payout Ratio (EPS, forward dividend) | 44.5% |
| Payout Ratio (FCF, forward dividend) | 105.9% |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2026-08-17 | $0.5792 | 2026-08-25 |
| 2026-03-30 | $1.2174 | 2026-04-08 |
| 2025-08-18 | $0.5843 | 2025-08-26 |
| 2025-03-31 | $1.1426 | 2025-04-08 |
| 2024-08-16 | $0.5169 | 2024-08-26 |
| 2024-03-22 | $0.9293 | 2024-04-02 |
| 2023-08-18 | $0.4382 | 2023-08-29 |
| 2023-03-24 | $0.5903 | 2023-04-04 |
| 2022-08-12 | $0.2889 | 2022-08-23 |
| 2022-03-25 | $0.5112 | 2022-04-05 |
| 2021-08-16 | $0.2751 | 2021-08-25 |
| 2021-03-26 | $0.4611 | 2021-04-07 |

Full history: https://www.dividenddata.com/stocks/nvo/dividend

## Frequently Asked Questions

### What does Novo Nordisk A/S do?

Novo Nordisk A/S (NVO) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is NVO's market cap?

Novo Nordisk A/S (NVO) has a market capitalization of approximately $174.58 billion, as of October 22, 2026, based on the most recent share price and shares outstanding.

### Does NVO pay a dividend?

Yes, Novo Nordisk A/S (NVO) pays a dividend semi-annually, with a trailing-twelve-month yield of 4.56%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

### How often does NVO pay dividends?

Novo Nordisk A/S pays dividends semi-annually. The forward annual rate is $1.80 per share at the current declared cadence. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is NVO's payout ratio?

Novo Nordisk A/S's payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/nvo
- Dividend history & safety: https://www.dividenddata.com/stocks/nvo/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/nvo/earnings
- Financial statements: https://www.dividenddata.com/stocks/nvo/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/nvo/valuation
- Peer comparison: https://www.dividenddata.com/stocks/nvo/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.